590 results on '"Conley, David B"'
Search Results
2. Associations Between Chronic Rhinosinusitis and the Development of Non–Cystic Fibrosis Bronchiectasis
3. Single cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissue
4. IL-13 and IL-13–induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis
5. ACR Appropriateness Criteria® Cranial Neuropathy: 2022 Update
6. Prevalence of Bronchiectasis in Patients with Chronic Rhinosinusitis in a Tertiary Care Center
7. Development and Preliminary Validation of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)
8. Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)
9. Clinical factors associated with acute exacerbations of chronic rhinosinusitis
10. Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps
11. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps
12. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis
13. ACR Appropriateness Criteria® Neck Mass-Adenopathy
14. Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting
15. The Clinical Significance of Specific Antibody Deficiency (SAD) Severity in Chronic Rhinosinusitis (CRS)
16. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase
17. Balloon Dilatation of the Maxillary, Frontal, and Sphenoid Sinuses
18. Contributors
19. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis
20. Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps
21. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
22. Clinical Characteristics of Adults With Chronic Rhinosinusitis and Specific Antibody Deficiency
23. Retinoic acid promotes fibrinolysis and may regulate polyp formation
24. Epidemiology of Nasal Polyps
25. IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells
26. Postoperative Medical Management
27. Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps
28. Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps
29. Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype
30. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease
31. Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis
32. Use of intraoperative frontal sinus mometasone‐eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps
33. Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps
34. CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis
35. Anti‐phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps
36. Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis
37. Chronic rhinosinusitis in the setting of other chronic inflammatory diseases
38. Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype.
39. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois
40. The dilemma of midline destructive lesions: a case series and diagnostic review
41. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis
42. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps
43. Effectiveness of a simulation-based mastery learning to train clinicians on a novel cricothyrotomy procedure at an academic medical centre during a pandemic: a quasi-experimental cohort study
44. Utility of Point-of-Care COVID-19 Testing in an Outpatient Otolaryngology clinic
45. Radiographic disease severity in chronic rhinosinusitis patients and health care utilization
46. Age-Related Increased Prevalence of Asthma and Nasal Polyps in Chronic Rhinosinusitis and Its Association with Altered IL-6 Trans-Signaling
47. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease
48. Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia
49. International Consensus Statement on Rhinology and Allergy: Rhinosinusitis
50. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.